Cargando…
High-dose chemotherapy of metastatic breast cancer: the end of the beginning?
Autor principal: | Crown, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063305/ https://www.ncbi.nlm.nih.gov/pubmed/9052394 |
Ejemplares similares
-
Primary chemotherapy in breast cancer: The beginning of the end or the end of the beginning for the surgical oncologist?
por: Heys, Steven D, et al.
Publicado: (2003) -
Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2022) -
“Omic” landscapes of breast cancer - the end of the beginning
por: Caldas, Carlos
Publicado: (2010) -
Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?
por: Lazzari, Chiara, et al.
Publicado: (2018) -
Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer
por: Malinovszky, K M, et al.
Publicado: (2006)